The Effect of Topical Autologous Serum on Graft Re-epithelialization After Penetrating Keratoplasty

被引:46
作者
Chen, Yan-Ming [1 ,3 ,4 ]
Hu, Fung-Rong [1 ,2 ]
Huang, Jehn-Yu [1 ]
Shen, Elizabeth P. [1 ,3 ,5 ]
Tsai, Tzu-Yun [1 ,3 ]
Chen, Wei-Li [1 ,2 ]
机构
[1] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan
[2] Natl Taiwan Univ Hosp, Ctr Corneal Tissue Engn & Stem Cell Biol, Taipei, Taiwan
[3] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan
[4] I Shou Univ, E Da Hosp, Dept Ophthalmol, Kaohsiung, Taiwan
[5] Buddhist Tzu Chi Gen Hosp, Dept Ophthalmol, Taipei, Taiwan
关键词
CORNEAL EPITHELIAL BARRIER; ALDOSE REDUCTASE INHIBITOR; DIABETES-MELLITUS; BASEMENT-MEMBRANE; EYE DROPS; DEFECTS; REEPITHELIALIZATION; SENSITIVITY;
D O I
10.1016/j.ajo.2010.03.024
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE: To analyze factors influencing corneal graft re-epithelialization after penetrating keratoplasty (PK) and evaluate the effect of topical autologous serum in promoting graft re-epithelialization. DESIGN: Prospective interventional study. METHODS: We analyzed 165 eyes of 165 patients who underwent PK between January 1, 2005 and December 31, 2007. Patients were divided into 2 groups according to routine use or non-use of postoperative 20% topical autologous serum. Postoperative slit-lamp examination after fluorescein staining was performed, and graft re-epithelialization time was recorded. Recipient/donor characteristics, surgical variables, and topical use of autologous serum were analyzed for their effects on post-PK graft re-epithelialization. Statistical analysis was performed by univariate and multivariate regression analysis using the ordinal logistic fit model to assess the potential risk factors influencing graft re-epithelialization after PK. RESULTS: In univariate analysis, diabetes mellitus (DM), longer death-to-storage time and death-to-surgery time of the donor, and larger recipient size significantly delayed graft re-epithelialization (P < .05). Use of autologous serum significantly expedited graft re-epithelialization (P = .004). In multiple regression analysis, only DM in the recipient (odds ratio [OR] = 5.10, P < .001), postoperative use of autologous serum (OR = 0.54, P = .046), and larger graft size (OR = 4.44, P < .001) influenced graft re-epithelialization. The beneficial and healing effect of autologous serum is particularly significant in diabetic recipients and larger grafts. CONCLUSIONS: Several factors may influence graft re-epithelialization after PK. Graft re-epithelialization time was longer in diabetic recipients and larger grafts. Use of autologous serum may be a beneficial strategy in these patients with potentially delayed epithelial healing.
引用
收藏
页码:352 / 359
页数:8
相关论文
共 56 条
[11]   Treatment of recurrent corneal erosions using autologous serum [J].
del Castillo, JMB ;
de la Casa, JMM ;
Sardiña, RC ;
Fernández, RM ;
Feijoo, JG ;
Gómez, AC ;
Rodero, MM ;
Sánchez, JG .
CORNEA, 2002, 21 (08) :781-783
[12]   Influence of topical human epidermal growth factor on postkeratoplasty re-epithelialisation [J].
Dellaert, MMMJ ;
Casey, TA ;
Wiffen, S ;
Gordon, J ;
Johnson, P ;
Geerards, AJM ;
Rijneveld, WJ ;
Remeijer, L ;
Mulder, PGH ;
Beekhuis, WH .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1997, 81 (05) :391-395
[13]   Use of autologous serum in corneal epithelial defects post-lamellar surgery [J].
Esquenazi, S ;
He, JC ;
Bazan, HEP ;
Bazan, NG .
CORNEA, 2005, 24 (08) :992-997
[14]  
*EY BANK ASS AM, 2002, PROC MAN
[15]   CORNEAL EPITHELIAL CHANGES IN DIABETIC RATS [J].
FRIEND, J ;
ISHII, Y ;
THOFT, RA .
OPHTHALMIC RESEARCH, 1982, 14 (04) :269-278
[16]   Corneal epithelial barrier function in diabetic patients [J].
Gekka, M ;
Miyata, K ;
Nagai, Y ;
Nemoto, S ;
Sameshima, T ;
Tanabe, T ;
Maruoka, S ;
Nakahara, M ;
Kato, S ;
Amano, S .
CORNEA, 2004, 23 (01) :35-37
[17]   IMPAIRMENT OF CORNEAL EPITHELIAL BARRIER FUNCTION IN DIABETICS [J].
GOBBELS, M ;
SPITZNAS, M ;
OLDENDOERP, J .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 1989, 227 (02) :142-144
[18]   Treatment of superior limbic keratoconjunctivitis by application of autologous serum [J].
Goto, E ;
Shimmura, S ;
Shimazaki, J ;
Tsubota, K .
CORNEA, 2001, 20 (08) :807-810
[19]  
HATCHELL DL, 1983, ARCH OPHTHALMOL-CHIC, V101, P469
[20]  
HERSE PR, 1988, AM J OPTOM PHYS OPT, V65, P224